Statistics for Oxford Biomedica PLC (id:3557 OXB)
Valuation metrics
Market cap
454.48M
Enterprise value
482.98M
Trailing P/E (ttm)
Forward P/E
3.00
PEG ratio
3.00
Price/Sales (ttm)
4.67
Price/Book (mrq)
678.06
Enterprise Value/Revenue
4.96
Enterprise Value/EBITDA
-8.63
Overview
Shares outstanding
105.94M
Float
69.08M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
146.03K
Average volume (90 days)
Price summary
52-Week low
167.00
52-Week high
450.00
52-Week change
50.12%
Beta
1.05
50-Day moving average
406.93
200-Day moving average
323.66
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
May 30, 2018
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
-145.98%
Operating margin
-60.50%
Operational effectiveness
Return on assets
-12.67%
Return on equity
-124.66%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
39.73M
EBITDA
-55,942,000.00
Net income to common (ttm)
-142,019,008.00
Diluted EPS (ttm)
-1.44
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
81.41M
Total cash per share (mrq)
3.00
Total debt (mrq)
110.31M
Total Debt/Equity (mrq)
154.88
Current ratio (mrq)
234.80%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-62,302,000.00
Levered free cash flow (LFCF)
-34,929,624.00